Toronto Dominion Bank
PVLA

Toronto Dominion Bank’s Palvella Therapeutics PVLA Stock Holding History

Toronto Dominion Bank’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,500
Closed -$157K – 2323
2025
Q3 		$157K Sell
2,500
-15,000
-86% -$669K ﹤0.01% 1428
2025
Q2 		$394K Sell
17,500
-1,372
-7% -$32.2K ﹤0.01% 1215
2025
Q1 		$528K Buy
18,872
+5,661
+43% +$109K ﹤0.01% 1152
2024
Q4 		$180K Buy
+13,211
New +$208K ﹤0.01% 1282

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Toronto Dominion Bank's PVLA Position: Q4 2025 in Review

Toronto Dominion Bank sold out of Palvella Therapeutics (PVLA) in Q4 2025, closing a stake of 2,500 shares — an estimated $157K sold.

Toronto Dominion Bank first reported a position in PVLA in Q4 2024 and held it in 4 quarters. The position peaked at $528K in Q1 2025. 140 funds tracked by Wall St. Rank hold PVLA as of Q4 2025.

  • Toronto Dominion Bank reported no remaining Palvella Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 2,500 Palvella Therapeutics shares in Q4 2025, an estimated $157K.
  • Toronto Dominion Bank first reported a position in Palvella Therapeutics in Q4 2024 and held it in 4 quarters.
  • Toronto Dominion Bank's Palvella Therapeutics position peaked at $528K in Q1 2025.
  • 140 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q4 2025.

Based on Toronto Dominion Bank's 13F filing for Q4 2025, filed 17 Feb 2026.